Jeremy Hodson Pettus MD
Diabetes, Lipid Metabolism
University of Califronia, San Diego
Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 858-657-1636
Fax+1 858-657-1626
Dr. Pettus is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston University School of MedicineClass of 2007
University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism
Certifications & Licensure
CA State Medical License 2008 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Clinical Trials
- A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function Start of enrollment: 2021 Jan 12
Roles: Contact
- Closed Loop and Education for Hypoglycemia Awareness Restoration Start of enrollment: 2025 Oct 03
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- The Role of Incretins in Obstructive Sleep Apnea "GLP1RAs and GLP1RA/GIPRAs in OSA".Ana Lucia Fuentes, Gurleen Dhami, Jeremy Pettus, Praveen Akuthota, Atul Malhotra
Journal of Diabetes. 2025-11-01 - Authors' Reply: Acetazolamide and Renal Hemodynamics: Interplay between Tubuloglomerular Feedback and Renin-Angiotensin-Aldosterone System Adaptation.Charles Ginsberg, Jeremy Pettus, Joachim H Ix
Journal of the American Society of Nephrology. 2025-05-12 - 4 citationsAcetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1.Charles Ginsberg, Jesse C Seegmiller, Volker Vallon, Sami SeungMi Jin, Robert L Thomas
Journal of the American Society of Nephrology. 2025-03-01
Press Mentions
Should ‘Time in Tight Range’ Be the Primary Diabetes Goal?March 25th, 2025- Type 1 Diabetes and Early Screening: Advances in Detection, Treatment, and Stories of HopeOctober 31st, 2024
- Biomea Fusion, Inc. Announces Formation of Global Scientific Advisory Board with 22 World-Renowned Diabetes ExpertsOctober 1st, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
